wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34452673-48A1E3BF-82C8-4B9C-A036-3C87B232BA6F
Q34452673-48A1E3BF-82C8-4B9C-A036-3C87B232BA6F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34452673-48A1E3BF-82C8-4B9C-A036-3C87B232BA6F
Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy.
P2860
Q34452673-48A1E3BF-82C8-4B9C-A036-3C87B232BA6F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34452673-48A1E3BF-82C8-4B9C-A036-3C87B232BA6F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ebf443c0dfdd2271ad2875c1e4ec25bbee904f2c
P2860
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials.